A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
Solo titulares de alta señal — eventos macro, earnings, M&A, regulación. Listicles y clickbait de analistas filtrados por defecto. Refrescado cada hora.
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Teradyne (TER) has drawn fresh attention after its stock closed at $363.38, capping a period where returns ranged from a small decline over the past month to a much stronger gain over the past 3 months. See our latest analysis for Teradyne. Recent share price moves suggest momentum is still building, with a 1 day share price return of 1.38% and a 90 day share price return of 15.48%, while the 1 year total shareholder return is very large. If Teradyne’s recent strength has you thinking about...
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly susceptible to drawdowns when market sentiment shifts.
As Teradyne has significantly outperformed the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
FTSE 100 down 39 points at 10,230 UK gilts near recent highs amidst possible Starmer exit Intertek received higher offer from private equity suitor Vodafone, Imperial Brands, Wickes report results 2.49pm: US stocks open lower Wall Street has joined in the selling party. The...
Teradyne's SemiTest segment tops $1.1B in Q1 2026 as AI demand neared 70% of revenue, backed by new test platforms and upbeat Q2 sales guidance.
Teradyne, Inc. (NASDAQ:TER) is one of the 14 Stocks That Will Skyrocket. Green starts strong with this particular stock. He tells anyone who’s interested that fret not, if you’ve missed investing in AI GPU giant NVIDIA, and says “this is your chance to get in on the next phase.” Another stock that’s pitched to benefit […]
We just covered Cathie Wood’s 11 Biggest AI and Data Center Stock Picks. Teradyne, Inc. (NASDAQ:TER) ranks #4 (see Cathie Wood’s 5 Biggest AI and Data Center Stock Picks). Cathie Wood’s Stake: $456,077,004 Teradyne Inc (NASDAQ:TER) is perhaps the most notable AI pick in Cathie Wood’s portfolio. Its bull case is simple: with everyone going hungry for […]
Teradyne, Inc. recently reported first-quarter 2026 results showing sales of US$1,282.49 million and net income of US$398.91 million, and issued second-quarter revenue guidance of US$1,150 million to US$1,250 million with GAAP diluted EPS of US$1.83 to US$2.12. With AI-related applications now contributing nearly 70% of revenue and a quarterly dividend of US$0.13 per share declared, Teradyne’s earnings profile is increasingly tied to AI infrastructure spending while still returning cash to...
According to the average brokerage recommendation (ABR), one should invest in Teradyne (TER). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Teradyne’s fair value estimate has been lifted from US$307.41 to US$369.53, pointing to a meaningfully higher modeled equity value in recent updates. This reset comes alongside a wave of Street research where many firms have raised price targets and some have issued upgrades, while others have turned cautious on how much optimism is already reflected in the stock. As you read on, you will see how to interpret these shifting targets and use the evolving analyst narrative to frame your own...
Teradyne, Inc. (NASDAQ:TER) is one of the 10 AI Stocks with Potential to Rise 1000 Percent. On April 30, 2026, Goldman Sachs raised its price target on Teradyne, Inc. (NASDAQ:TER) to $350 from $300 and maintained a Buy rating. The firm said the company delivered a strong quarter that may have been overshadowed by elevated […]
The companies are reporting strong earnings growth fueled in part by data center and robotics demand. Elon Musk also teased Tesla’s Optimus as its "biggest product ever."
Teradyne and Qualcomm take center stage as AI-driven growth powers TER's surge, while QCOM faces pressure from declining handset sales.
70% of revenue is now AI-related for this chip testing powerhouse that just grew EPS 241%
Teradyne, Inc. (NASDAQ:TER) was among the stocks Jim Cramer highlighted, as he discussed the massive AI infrastructure buildout. Cramer mentioned the stock during the episode and commented: Then there’s Teradyne. Okay, now this is a little more arcane. This is, it’s up 12%. It’s not new. It’s been a tremendous performer during the data center […]
The company's recent earnings report didn't quite live up to lofty expectations, but long-term investors might see the recent decline as a buying opportunity.
Shares of semiconductor testing company Teradyne (NASDAQ:TER) jumped 13.8% in the afternoon session after the company reported record-breaking first-quarter 2026 financial results that surpassed analyst expectations, driven by strong demand for artificial intelligence applications.
Teradyne (TER) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Teradyne's (TER) results reflect an "expectations issue" rather than a miss, as investor optimism ar
Meta downgraded, Qualcomm upgraded: Wall Street's top analyst calls
Pre-Market Stock Futures: Futures are trading higher this morning after a messy Wednesday trading session that saw all major indices except the Nasdaq end lower, with the Nasdaq closing virtually unchanged at 24,603, up 0.04%. The combination of soaring oil prices, the Federal Reserve keeping interest rates unchanged for the third straight meeting, and bogged-down ... Here Are Thursday’s Top Wall Street Analyst Research Calls: AbbVie, Equinix, GE Healthcare, Kratos Defense, Meta Platforms, Oneok